118 related articles for article (PubMed ID: 2551314)
1. Cytomegalovirus infection and disease in renal transplant patients treated with cyclosporin. A prospective study.
Bosch FH; Hoitsma AJ; Janssen HP; van Loon AM; Koene RA
Transpl Int; 1989 Aug; 2(2):92-5. PubMed ID: 2551314
[TBL] [Abstract][Full Text] [Related]
2. The impact of cytomegalovirus infection on seronegative recipients of seropositive donor kidneys versus seropositive recipients treated with cyclosporine-prednisone immunosuppression.
Johnson PC; Lewis RM; Golden DL; Oefinger PE; Van Buren CT; Kerman RH; Kahan BD
Transplantation; 1988 Jan; 45(1):116-21. PubMed ID: 2827353
[TBL] [Abstract][Full Text] [Related]
3. The adverse impact of cytomegalovirus infection on clinical outcome in cyclosporine-prednisone treated renal allograft recipients.
Lewis RM; Johnson PC; Golden D; Van Buren CT; Kerman RH; Kahan BD
Transplantation; 1988 Feb; 45(2):353-9. PubMed ID: 2830686
[TBL] [Abstract][Full Text] [Related]
4. Cytomegalovirus-related disease and risk of acute rejection in renal transplant recipients: a cohort study with case-control analyses.
Toupance O; Bouedjoro-Camus MC; Carquin J; Novella JL; Lavaud S; Wynckel A; Jolly D; Chanard J
Transpl Int; 2000; 13(6):413-9. PubMed ID: 11140239
[TBL] [Abstract][Full Text] [Related]
5. Incidence of cytomegalovirus infections in renal transplant patients treated with conventional or cyclosporin therapy.
Guerin C; Pozzetto B; Genin C; Berthoux FC; Gaudin OG
Nephrol Dial Transplant; 1988; 3(1):77-80. PubMed ID: 2837679
[TBL] [Abstract][Full Text] [Related]
6. Cytomegalovirus infections in renal transplant recipients. Correlation between clinical disease and results of a specific ELISA.
Metselaar HJ; Rotbarth PH; Kramer P; Bijnen AB; Jeekel J; Masurel N; Weimar W
Antiviral Res; 1985; Suppl 1():127-30. PubMed ID: 3002252
[No Abstract] [Full Text] [Related]
7. Cytomegalovirus disease in renal allograft recipients: a prospective study of the clinical features, risk factors and impact on renal transplantation.
Peterson PK; Balfour HH; Marker SC; Fryd DS; Howard RJ; Simmons RL
Medicine (Baltimore); 1980 Jul; 59(4):283-300. PubMed ID: 6248718
[TBL] [Abstract][Full Text] [Related]
8. Cytomegalovirus as a risk factor in living-related renal transplantation. A prospective study.
Pollak R; Barber PL; Prusak BF; Mozes MF
Ann Surg; 1987 Mar; 205(3):302-4. PubMed ID: 3030201
[TBL] [Abstract][Full Text] [Related]
9. The problem of cytomegalovirus infection in renal allograft recipients.
Kurtz JB; Thompson JF; Ting A; Pinto A; Morris PJ
Q J Med; 1984; 53(211):341-9. PubMed ID: 6091169
[TBL] [Abstract][Full Text] [Related]
10. Cytomegalovirus infection--an etiological factor for rejection? A prospective study in 242 renal transplant patients.
Pouteil-Noble C; Ecochard R; Landrivon G; Donia-Maged A; Tardy JC; Bosshard S; Colon S; Betuel H; Aymard M; Touraine JL
Transplantation; 1993 Apr; 55(4):851-7. PubMed ID: 8386406
[TBL] [Abstract][Full Text] [Related]
11. Reassessing the impact of cytomegalovirus infection in kidney and kidney-pancreas transplantation.
Becker BN; Becker YT; Leverson GE; Simmons WD; Sollinger HW; Pirsch JD
Am J Kidney Dis; 2002 May; 39(5):1088-95. PubMed ID: 11979354
[TBL] [Abstract][Full Text] [Related]
12. Cyclosporin A in renal transplantation: a prospective randomized trial.
Ferguson RM; Rynasiewicz JJ; Sutherland DE; Simmons RL; Najarian JS
Surgery; 1982 Aug; 92(2):175-82. PubMed ID: 6285533
[TBL] [Abstract][Full Text] [Related]
13. Severe graft rejection, increased immunosuppression, and active CMV infection in renal transplantation.
von Müller L; Schliep C; Storck M; Hampl W; Schmid T; Abendroth D; Mertens T
J Med Virol; 2006 Mar; 78(3):394-9. PubMed ID: 16419118
[TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus infection and graft rejection in renal transplantation.
Dickenmann MJ; Cathomas G; Steiger J; Mihatsch MJ; Thiel G; Tamm M
Transplantation; 2001 Mar; 71(6):764-7. PubMed ID: 11330539
[TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus infection after kidney transplantation using cyclosporin A and low-dose prednisolone immunosuppression.
Mayer G; Watschinger B; Pohanka E; Graf H; Popow T; Ulrich W; Kovarik J
Nephrol Dial Transplant; 1988; 3(4):464-8. PubMed ID: 2845305
[TBL] [Abstract][Full Text] [Related]
16. The impact of cyclosporine therapy on the occurrence of infection in the renal transplant recipient.
Tolkoff-Rubin NE; Rubin RH
Transplant Proc; 1986 Apr; 18(2 Suppl 1):168-76. PubMed ID: 3008389
[No Abstract] [Full Text] [Related]
17. Incidence of cytomegalovirus disease in cyclosporine-treated renal transplant recipients based on donor/recipient pretransplant immunity.
Weir MR; Irwin BC; Maters AW; Genemans G; Shen SY; Charache P; Williams GM
Transplantation; 1987 Feb; 43(2):187-93. PubMed ID: 3027930
[TBL] [Abstract][Full Text] [Related]
18. Prospective study of the prevalence and symptomatology of cytomegalovirus infection in renal transplant recipients.
Chatterjee SN; Jordan GW
Transplantation; 1979 Dec; 28(6):457-60. PubMed ID: 229594
[TBL] [Abstract][Full Text] [Related]
19. 1,25 Dihydroxyvitamin D circulating levels, calcitriol administration, and incidence of acute rejection, CMV infection, and polyoma virus infection in renal transplant recipients.
Moscarelli L; Antognoli G; Buti E; Dervishi E; Fani F; Caroti L; Tsalouchos A; Romoli E; Ghiandai G; Minetti E
Clin Transplant; 2016 Oct; 30(10):1347-1359. PubMed ID: 27532453
[TBL] [Abstract][Full Text] [Related]
20. [Factors influencing prevalence and clinical course of cytomegalovirus (CMV) infection in kidney transplant patients].
Szymczakiewicz-Multanowska AM; Kuźniewski M; Zawilińska B; Zgórniak-Nowosielska I; Uracz D; Ignacak E; Betkowska-Prokop A; Sułowicz W
Przegl Lek; 2001; 58(7-8):772-7. PubMed ID: 11769385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]